| Date | Title | Description |
| 25.08.2026 | Three Swiss biotechs promote from within |
Lausanne-based Avrion Therapeutics, an EPFL spin-off founded in 2020, has appointed co-founder Maximilien Murone as interim Chief Executive Officer in June. He succeeds Harald Petry, who has led the preclinical-stage biotech since 2022 and... |
| 24.06.2026 | Nicole Herzog zur «Business Angel of the Year 2026» gekürt |
Nicole Herzog wurde gestern im Rahmen der SECA Sommerparty geehrt. Die Mitgründerin des Early-Stage-VC b2venture und des Anbieters für webbasiertes Talent- und Leistungsmanagement umantis investiert seit dem umantis Exit im Jahr 2012 in Sc... |
| 19.06.2026 | Swiss biotechs display their innovations at BIO 2026 in San Diego |
The BIO International Convention attracts over 1,600 exhibitors and 21,000 attendees who network intensively over 4 days, discover new opportunities and promising partnerships. The attendees benefit from a broad spectrum of life sciences a... |
| 26.05.2026 | InSphero acquires PhenoVista to expand US presence |
Founded in 2009 as a spin-off from ETH Zurich, Schlieren-based InSphero develops 3D in vitro models for drug safety and efficacy testing. Its spheroid-based models—clusters of cells grown in three dimensions to mimic human tissue more clos... |
| 21.05.2026 | InSphero Accelerates Global Growth and US Expansion with Acquisition of PhenoVista Biosciences | Strategic acquisition strengthens InSphero’s US presence and expands advanced imaging and phenotypic analysis capabilities for drug discovery and safety testing
This acquisition helps us better serve customers by combining cutting-edge biol... |
| 14.04.2026 | InSphero Launches 3D InSight™ DIGIT Platform for Early Gastrointestinal Toxicity Assessment | New Offering Integrates DOPPL’s Patient-Derived Intestinal Organoid Technology with InSphero’s Proven Standardized Screening Model SCHLIEREN , SWITZERLAND, April 14, 2026 /EINPresswire.com/ -- New Offering Integrates DOPPL’s Patient-Derived... |
| 11.02.2026 | InSphero and PharmaNest From a Partnership to Advance Translational Fibrosis Research | SCHLIEREN, ZURICH, SWITZERLAND, February 11, 2026 /EINPresswire.com/ -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed a partnership with PharmaNest Inc, a Princeton, NJ-based digital patholog... |
| 10.02.2026 | Industry Leaders Announce World’s First Microphysiological Systems Industry Association (IAMPS) | BRUSSELS, BELGIUM, February 10, 2026 /EINPresswire.com/ -- European microphysiological systems (MPS) industry leaders, Alveolix (Switzerland); BiomimX (Italy); Chiron (Netherlands); Dynamic42 (Germany); InSphero (Switzerland); MIMETAS (Neth... |
| 12.11.2025 | InSphero acquires DOPPL SA and Sun Bioscience Gri3D Technology | Founded in 2016, Sun Bioscience is the manufacturer of the Gri3D organoid culture platform, an SBS-standard microwell plate technology that enables the formation of uniform organoids with high reproducibility and compatibility for automated... |
| 02.09.2025 | AI-driven drug discovery picks up as FDA pushes to reduce animal testing | Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future.
Within the next three to five years, using ... |
| 19.06.2025 | Brenus Pharma and InSphero have developed 3D tumor spheroids mimicking in vivo human colorectal cancer conditions | PPromising results show the impact of Brenus Pharma and InSphero’s collaboration in advancing translational immunotherapy through scalable 3D tumor models.
We are proud to support Brenus with our cryopreserved 3D tumor models. This work ill... |
| 29.01.2025 | Venture Kick alumni: job creation and investment strengthen Swiss economy |
The Venture Kick Annual Report 2024 highlights the continued success of the Kick Foundation initiative in solidifying Switzerland’s position as a global innovation leader. In 2024, Venture Kick experienced significant growth in startup app... |
| 28.01.2025 | CHF 9 Billion Invested in Venture Kick Startups | In 2024, Venture Kick reviewed 880 applications and invested CHF 6.7 million in 97 new startup projects. Applications grew by 13% year-on-year up from 781 in 2023, covering a wide range of high-tech fields: ICT, biotech, medtech, cleantech,... |
| 03.12.2024 | Biotech startups celebrate new achievements |
AC Immune, a biopharmaceutical company focused on neurodegenerative diseases, has reported positive interim results from its Phase 2 VacSYn clinical trial evaluating ACI-7104.056, an active immunotherapy targeting alpha-synuclein for early... |
| 25.11.2024 | InSphero and FDA’s NCTR Publish the Largest Benchmarking Study on Early-stage Liver Toxicity Using 3D Liver Microtissues | InSphero's 3D InSight™ Human Liver Microtissues Cultivated with Akura™ 384 Spheroid Microplate
3D InSight™ Human Liver Microtissues
InSphero logo
InSphero’s 3D liver microtissues predicted liver toxicity with 80% accuracy in a study with 15... |
| 20.11.2024 | The Rise of 3D Printing: A New Era in Manufacturing and Medicine | The world of manufacturing and medicine is undergoing a seismic shift. 3D printing, once a niche technology, is now a cornerstone of innovation. Companies like Spectroplast and InSphero are leading the charge, pushing boundaries and redefin... |
| 19.11.2024 | InSphero secures an EU grant to advance diversity in 3D in vitro testing | Launched in May 2024, the Project UNLOOC - Unlocking data content of Organ-on-Chips - brings together 51 organizations in academia, research, and technology companies from 10 European countries. With an overall budget of EUR 68 million, the... |
| 19.11.2024 | EU grants to fuel Research and development at Insphero and Onward Medical |
InSphero, the global leader in scalable and reliable 3D in vitro cell culture solutions for drug discovery, is taking a leading role in the recently awarded Chips JU European UNLOOC – Unlocking data content of Organ-on-Chips– Project. The ... |
| 08.11.2024 | Bio-Europe: Switzerland's Biotech Showcase in Stockholm | The heart of Europe beats strong in Stockholm this November. Bio-Europe, the continent's premier partnering event for the life sciences, is back for its 30th edition. This year, it promises to be a melting pot of innovation, collaboration, ... |
| 05.11.2024 | Bio Europe in Stockholm hosts 33 Swiss companies |
Currently in its 30-year-edition, BIO-Europe remains Europe's leading partnering event, for the life sciences ecosystem, providing an exceptional opportunity to explore the latest trends learn and connect with potential partners. The past ... |
| 17.09.2024 | From Glial Cells to Beta Cells: Swiss companies receive grants to tackle health challenges |
GliaPharm, an EPFL spinoff biotech company that develops innovative approaches to treat neurological and psychiatric disorders has received BRAINS grant to support a four-year study into the behavior of glial cells in various brain disease... |
| 13.09.2024 | Maximize your EIC Funding: Webinar on unlocking business opportunities with Europe’s largest corporations | The European Innovation Council (EIC) Corporate Partnership Programme has been instrumental in fostering collaborations between EIC-funded startups and Europe’s leading corporations. Since its launch in 2017, the programme has facilitated o... |
| 19.08.2024 | InSphero, Breakthrough T1D and Université libre de Bruxelles Collaborate to Find New Cures for Type 1 Diabetes | InSphero, Breakthrough T1D, and Université Libre de Bruxelles Collaborate to Find New Cures for Type 1 Diabetes
InSphero, Breakthrough T1D, and ULB partner to discover novel T1D treatments, aiming to protect and preserve vital insulin-produ... |
| 31.05.2024 | Swiss life science startups headed for San Diego |
The BIO International Convention 2024, taking place in San Diego from 3 to 6 June, is the largest global biotechnology event with over 20,000 industry leaders from around the world attending. The target group includes representatives from ... |
| 22.05.2024 | "EMBRACING INTERNATIONAL ALLIANCES" SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024 INTERNATIONAL CONVENTION IN SAN DIEGO JUNE 3-6, 2024 | ZURICH, May 22, 2024 /PRNewswire/ -- Swiss life science innovation will again be on display at the BIO 2024 convention in San Diego. Switzerland Global Enterprise will present 41 leading Swiss biotech stars at the SWISS BIOTECH pavilion dem... |
| 16.05.2024 | InSphero Secures Exclusive Commercialization Partnership with Genome Biologics for 3D Cardiac Organoid Platform | InSphero AG is pleased to announce its exclusive commercialization of TrueCardium® Cardiac Organoid Platform in partnership with Genome Biologics. SCHLIEREN, ZURICH, SWITZERLAND, May 16, 2024 /EINPresswire.com/ -- In a significant expansion... |
| 15.03.2024 | InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery in a Breakthrough Study | InSphero published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery. SCHLIEREN, ZURICH, SWITZERLAND, March 15, 2024 /EINPresswire.com/ -- InSphero's L... |
| 17.11.2023 | InSphero to Revolutionize Oncology Research Through Advanced 3D Cell-Based Assays with ATCC | InSphero AG and ATCC will work together to introduce new paradigms in the rapidly evolving field of 3D cell-based oncology research.
Through this partnership with ATCC, we are fulfilling a long-standing ambition to open new avenues for adva... |
| 31.03.2023 | InSphero Accelerates Launch of Cryopreserved 3D Microtissue Platform with new Investment Round Led by ZEISS Ventures | 3D InSight™ Tumor Microtissue
Allows streamlining the R&D process for researchers desiring deeper insights in human biology by storable, ready-to-use 3D models
InSphero has uniquely positioned itself with its highly industrialized platf... |
| 23.01.2023 | InSphero and Brenus Pharma are awarded EUR 1.5 million grant for cancer research project | The collaborative project titled "STC-1010: A First-in-Class Allogeneic Cell Vaccine Against Cancer" is coordinated by Brenus in collaboration with InSphero and was launched in November 2022 and is set to take 36 months. The colla... |
| 23.01.2023 | InSphero and Brenus Pharma are awarded EUR 1.5 million grant for cancer research project | InSphero and Brenus Pharma are awarded EUR 1.5 million grant for cancer research project 23.01.2023 12:39, Morgane Ghilardi linkedIn facebook twitter instagram youtube -->
The Eurostar funding will support a research project aiming to us... |
| 15.02.2022 | Welcome back to the FDA, Robert Califf. Let’s get to work on your big idea | Now, more than ever, the U.S. needs scientific leaders who value Americans’ health and safety, who want to improve research and testing, and who are passionate about innovative ideas.
With Robert Califf once again confirmed as the commissio... |
| 26.11.2020 | New prizes and grants from three continents | |
| 26.11.2020 | New prizes and grants from three continents | Heat Force – COMEUP, Korea
Selected from 1075 applicants, Heart Force from Zurich is among the 120 winners of the COMEUP Stars organised in Korea. The prize includes support for the creation of corporate promotional videos and online booths... |
| 05.08.2020 | Insphero among Red Dot’s Best of the Best Award winners | |
| 05.08.2020 | Insphero among Red Dot’s Best of the Best Award winners | The Red Dot Award recognises outstanding design achievements of designers and companies worldwide in roughly 50 categories based on criteria for excellent design standards and innovation. With more than 18,000 entries, the RedDot Award is o... |
| 19.05.2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | |
| 19.05.2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | BIO International Convention has transformed into BIO Digital to bring together players in the biotech industry to exchange ideas even in times when it is impossible to gather physically. From 8 - 12 June, more than 2300 companies from all ... |
| 13.05.2020 | Swiss Startups Tackling Corona Virus - COVID-19 | Swiss Startups Tackling Corona Virus - COVID-19 13.05.2020 13:14, Gianmaria Sbetta linkedIn facebook twitter instagram youtube -->
Corona Virus is changing our society, our economy and our lifestyle. Remote working and online collaborati... |
| 26.03.2020 | Tried and tested technologies to fight Coronavirus | |
| 26.03.2020 | Tried and tested technologies to fight Coronavirus | The world is battling against the Coronavirus as different players from medical workers to government members struggle to understand the virus and develop an immunization program for it, or to find the appropriate medication to treat patien... |
| 08.11.2019 | IPO Day: Deep-tech companies on stage | |
| 07.11.2019 | In honour of Swiss innovation | |
| 17.09.2019 | Twelve Swiss startups join Euronext’s Pre-Ipo programme Techshare | |
| 24.07.2019 | Insphero’s 3D liver disease testing platform launched in the market | |
| 19.03.2019 | Thirteen Swiss startups receive Eurostars grants | |
| 30.07.2018 | Insphero collaborates with the American Laboratory Products Company | |
| 18.06.2018 | InSphero grows further with $10 million funding round | The medtech’s drug discovery and testing platforms use ground-breaking, scaffold-free 3D microtissues – phenotypic models of the smallest functional unit of a tissue or organ – driven by cellular self-assembly. With organs grown in vitro in... |
| 18.06.2018 | InSphero grows further with $10 million funding round | InSphero grows further with $10 million funding round 18.06.2018 11:10, Robynn Weldon linkedIn facebook twitter instagram youtube -->
3D cell culture pioneer Insphero has raised new financing from internal and external investors, bringin... |
| 15.06.2018 | InSphero raises additional $10m | |
| 13.06.2018 | InSphero Raises $10M in Funding | InSphero, a Schlieren, Switzerland-based provider of 3D cell-based platforms for drug discovery and efficacy testing, raised $10m in funding.
The round brings total funding to date to USD$35m. Backers included former GM of Promega Switzerla... |
| 27.04.2017 | InSphero’s micro livers to help Pfizer to predict drug-induced liver injury | |
| 29.03.2017 | InSphero reduces Animal Testing with 3D InSight™ Monkey Liver Microtissues | Drug-induced liver injury (DILI) remains one of the most common causes of late-stage failure in drug development and post-market drug withdrawal. Testing in non-human primates is often required to assess toxicity and potential liver-related... |
| 29.03.2017 | InSphero reduces Animal Testing with 3D InSight™ Monkey Liver Microtissues | InSphero reduces Animal Testing with 3D InSight™ Monkey Liver Microtissues 29.03.2017 10:00, Tsering Ngorkhangsar linkedIn facebook twitter instagram youtube -->
InSphero was named #1 startup in the 2014 TOP 100 Swiss startups ranking an... |
| 07.11.2016 | InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System | The Global 3Rs Awards recognize significant innovative contributions toward the advancement of ethical science through the 3Rs of animal research: refinement, replacement, or reduction of animal use. Early October 2016, InSphero had met wit... |
| 07.11.2016 | InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System | InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System 07.11.2016 14:00, Lara Rossi linkedIn facebook twitter instagram youtube -->
Dr. Olivier Frey of InSphero AG has received the 2016 IQ Consortium and AAALAC... |
| 03.10.2016 | InSphero discusses technologies to reduce animal research with US Congressional Leaders | InSphero discusses technologies to reduce animal research with US Congressional Leaders 03.10.2016 14:00, Lara Rossi linkedIn facebook twitter instagram youtube -->
InSphero AG, the leading supplier of easy-to-use solutions for productio... |
| 02.09.2016 | Biointerfaces: Vom Labor auf den Markt | |
| 06.06.2016 | Jan Lichtenberg im Rennen um den EY World Entrepreneur Of The Year | |
| 07.03.2016 | The search for Insphero’s successor has began | |
| 11.02.2016 | Bilan reveals its Top 50 startup selection | |
| 10.02.2016 | Almost a billion invested in Venture Kick startups | |
| 25.01.2016 | Jan Lichtenberg of InSphero: “The days in Boston were phenomenal” | The startup InSphero is committed to the production and sales of high quality micro fabrics that are very similar to real human body tissue. The so-called “microtissues” can be used for more efficient drug development, which in turn could r... |
| 23.10.2015 | Jan Lichtenberg wird Entrepreneur of the Year | |
| 12.10.2015 | Redalpine Capital I Exits InSphero | Zurich, Switzerland-based Redalpine Capital I exited InSphero, a developer of organotypic 3D cell cultures for in-vitro testing, at a double-digit multiple.
The Schlieren-based company recently closed a CHF 20m Series C funding round with t... |
| 12.10.2015 | Successful exit for Redalpine with InSphero | |
| 22.09.2015 | Vier Startups im Final des Entrepreneur of the Year Awards | |
| 16.09.2015 | Schnelle Schweizer Life Sciences Startups | |
| 05.08.2015 | InSphero Expands Global Availability of its 3D Cell Culture Platforms | |
| 08.07.2015 | InSphero Secures CHF 20 Million Series C Financing | |
| 08.07.2015 | InSphero Secures CHF20M Series C Financing | InSphero, a Schlieren, Switzerland-based 3D cell culture company, raised CHF 20m in Series C financing.
The family investment office of a globally active entrepreneur represented through Zug, Switzerland-based HP Wild Holding AG made the in... |
| 08.07.2015 | TOP 100 Startup Award winner InSphero secures CHF 20 million series C financing | TOP 100 Startup Award winner InSphero secures CHF 20 million series C financing 08.07.2015 12:00, Tina Lohfing linkedIn facebook twitter instagram youtube -->
InSphero, Nr. 1 Swiss Startup of the Top 100 Swiss Startup Rankings 2014 and t... |
| 08.07.2015 | TOP 100 Startup Award winner InSphero secures CHF 20 million series C financing | Since its commercial launch in 2010, the company has experienced strong year-over-year sales growth marked by the rapid adoption of its 3D InSight™ microtissues and services by leading pharmaceutical, chemical and cosmetics companies. Since... |
| 08.07.2015 | Daily funding roundup - July 8, 2015 | WeWork raised $434M; Babbel nabbed $20M; Confluent closed $24M
WeWork, a company that sublets office space, along with amenities, including furniture and Internet, and other additional goodies, to budding entrepreneurs has been raising a lo... |
| 29.04.2015 | Vainqueur Prix Strategis 2015: eSmart | |
| 27.03.2015 | Startups mischen Export Award auf | |
| 20.03.2015 | Finalists of Prix Strategis announced | |
| 05.02.2015 | Bilan presents 50 start-ups looking for funding | |
| 01.12.2014 | Semi-finalists of Prix Strategis announced | |
| 10.10.2014 | InSphero wins ACES Award | |
| 18.09.2014 | Swiss Top 100 Start-ups Are Selected | |
| 05.08.2014 | InSphero finalist of the 2014 European academic enterprise awards | |
| 11.07.2014 | Insphero to enter the personalized medicine market with a new spin-off | |
| 07.07.2014 | Die Startupfair 2014 setzt neue Massstäbe | |
| 05.06.2014 | Eight start-ups selected for the Swiss Venture Day in Zurich | |
| 02.06.2014 | Startup-Battle 2014: Die Hightech-Finalisten stehen fest | |
| 07.05.2014 | Europäische Forschungsprogramme: Was für Startups auf dem Spiel steht | |
| 03.03.2014 | InSphero Granted Hanging Drop Patents in China and Japan | |
| 07.02.2014 | Startups schaffen 2`433 Jobs | |
| 16.01.2014 | Application open for venture leaders | |
| 05.12.2013 | InSphero gets funds from EUROSTARS for novel liver screening platform | |
| 26.11.2013 | InSphero opens EU office for speeding up delivery | |
| 02.10.2013 | Finalisten des Entrepreneur Of The Year-Wettbewerbs 2013 stehen fest | |
| 19.09.2013 | Insights and background information from the Top 100 Startups Awards | |
| 18.09.2013 | Housetrip erneut an die Spitze der Top 100 Start-ups gewählt | |
| 12.07.2013 | Pfizer und Roche veröffentlichen positive Studienresultate mit InSphero | |
| 18.06.2013 | InSphero Receives CHF2M in Series B Financing | InSphero AG, a Zurich, Switzerland-based provider of three-dimensional microtissue technology, received CHF2m in Series B financing.
The round – a mixture of equity capital and long-term loans – was led by unnamed existing and new investors... |
| 13.06.2013 | InSphero secures CHF 2 million financing | |
| 31.01.2013 | Insphero: Patent and New Product | |
| 22.11.2012 | Taiwanischer Minister zu Besuch bei venturelab | Anlass des Besuches der taiwanesischen Delegation ist eine alle vier Jahre stattfindende Konferenz zu Wissenschaft und Technologie. Eines der wichtigen Themen ist die berufliche Ausbildung und die Kooperation zwischen Hochschule und Industr... |
